With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
NEW YORK (Reuters Health) – Patients with macroprolactinemia don’t need extensive exams or prolonged monitoring, according to a prospective study. As long as their monomeric prolactin concentration is…
NEW YORK (Reuters Health) – A single yearly oral dose of 500,000 international units of cholecalciferol (vitamin D) does not protect generally healthy older women from falls and…
NEW YORK (Reuters Health) – Intravesical botulinum toxin improves overactive bladder symptoms, but with a significant risk of urinary retention, according to a meta-analysis reported April 19th in…
NEW YORK (Reuters Health) For surgical management of female stress urinary incontinence, tension-free midurethral tapes should be “the first option of treatment,” according to the lead author of…
Going through menopause is hard enough. Why should women go it alone? What’s Up With You Know Who is an informative, entertaining DVD that will explain the menopause…
Menopause in an Hour is an informative DVD and Guidebook. It provides you with medically sound, up-to-date information in a format that’s easy to understand and use. It’s…
NEW YORK (Reuters Health) – Women in Ecuador have a particularly high rate of fever and shivering with sublingual misoprostol – but whether this is due to altitude,…
NEW YORK (Reuters Health) – Up to 20% of tests for estrogen and progesterone receptors in breast cancers are false negatives or false positives, according to a consensus…
EW YORK (Reuters Health) – Annual testing for Chlamydia trachomatis doesn’t prevent many cases of pelvic inflammatory disease (PID), according to a prospective U.K. study published in BMJ…
NEW YORK (Reuters Health) – In new recommendations for the management of vulvodynia, the British Society for the Study of Vulval Diseases Guideline Group stresses a team approach…
